Dr. Sahm has over 25 years of experience in life science technology development and commercialization.  He has considerable experience with cardiovascular, pulmonary, neurological, urological, rehabilitation, and drug/device combination products.

With his broad background in engineering and medicine, Roger has performed many valuable functions for both start-up and established companies including business and regulatory strategy, intellectual property due diligence, market needs analysis, human factors and risk analysis engineering and validation, preclinical studies for proof-of-concept, clinical studies to establish safety and efficacy, and regulatory submissions.

His specialty is anticipating the questions that will be asked of a technology or product by clinicians, regulatory bodies, and reimbursement payers, and then pursuing the appropriate pathways to answer those questions.